Kromek Group plc (AIM: KMK), the County Durham-based radiation detection technology company, has announced a $1.4m follow-on order from an existing OEM customer in its Advanced Imaging division. The order covers the supply of cadmium zinc telluride (CZT)-based detector components for the customer's medical systems. Delivery is set to begin immediately and is expected to complete over the next 12 months, contributing revenue to both the current and next financial year.

Key Points

  • Kromek Group plc (AIM: KMK) — global detection company focused on advanced imaging and CBRN detection markets
  • Received a $1.4m follow-on order from an existing OEM customer for CZT-based detector components for medical systems
  • Delivery commences immediately and is expected to be completed over the next 12 months
  • Investors may watch for further follow-on order announcements and updates on Advanced Imaging division progress

CZT-Based Detector Components to Supply Existing OEM Medical Systems Customer

The order, announced on 5 November 2026, is for CZT-based detector components that form the core of Kromek's Advanced Imaging offering. CZT, or cadmium zinc telluride, is Kromek's proprietary detector platform, enabling OEM customers to build medical systems capable of detecting conditions such as cancer and Alzheimer's disease. The fact that this is a follow-on order from an existing customer underlines the embedded nature of Kromek's technology within the customer's product lifecycle, as detector components must be replaced or replenished once designed into a system.

Repeat Order Pattern Highlights Advanced Imaging Division's Revenue Visibility

Chief Executive Arnab Basu noted in the announcement that the order "reflects the repeat nature of business in our Advanced Imaging division, with a steady flow of follow-on orders once our detectors are designed into a system." The company states that delivery will contribute to growth in the current financial year and provide visibility into the next. This recurring revenue dynamic is a notable characteristic of Kromek's OEM model, where initial design wins tend to generate sustained component supply orders over extended periods, supporting forward revenue planning for the Group.

Kromek's Advanced Imaging Division Spans Medical, Security and Industrial Markets

Kromek's Advanced Imaging segment addresses three distinct end markets: medical imaging — including CT and SPECT scanning — industrial contamination detection, and aviation security screening for explosives. Headquartered in County Durham with manufacturing operations in both the UK and the United States, the Group supplies detector components to OEM customers globally. The CBRN detection segment, which operates alongside Advanced Imaging, provides compact radiation detectors for homeland defence and is separately developing bio-security systems to detect airborne pathogens, illustrating the breadth of Kromek's detection technology portfolio.

Order Contribution and 12-Month Delivery Timeline for Current and Next Financial Year

The $1.4m order will be delivered over a 12-month period commencing immediately, meaning revenue recognition is expected to span two financial years. For investors monitoring Kromek's growth trajectory on AIM, the announcement provides incremental revenue visibility at divisional level. The company indicated it expects to update the market on further progress within Advanced Imaging, suggesting additional order activity in this segment remains a key area of focus for management and shareholders alike.